Cite
HARVARD Citation
Prue, R. et al. (n.d.). A Phase I Clinical Trial of CD1c (BDCA-1)+ Dendritic Cells Pulsed With HLA-A*0201 Peptides for Immunotherapy of Metastatic Hormone Refractory Prostate Cancer. Journal of immunotherapy. 38 (2), p. . [Online].